Financial Ratios

KERALA AYURVEDA LTD.

NSE : NABSE : 530163ISIN CODE : INE817B01025Industry : Pharmaceuticals & DrugsHouse : Kerala Ayurveda - MNC
BSE272.855.3 (+1.98 %)
PREV CLOSE ( ) 267.55
OPEN PRICE ( ) 265.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8282
TODAY'S LOW / HIGH ( )263.30 277.00
52 WK LOW / HIGH ( ) 90329.75
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.740.84-4.690.831.14
   CEPS(Rs)3.341.57-3.921.471.67
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.057.826.6511.0412.78
   Tax Rate(%)-21.8227.9624.7227.8731.53
Margin Ratios
   Core EBITDA Margin(%)7.5213.850.485.796.46
   EBIT Margin(%)11.3513.03-1.014.828.55
   Pre Tax Margin(%)3.752.21-15.222.263.77
   PAT Margin (%)4.571.59-11.461.632.58
   Cash Profit Margin (%)5.582.97-9.572.903.79
Performance Ratios
   ROA(%)3.080.95-5.240.971.28
   ROE(%)29.0211.64-53.026.987.69
   ROCE(%)10.0010.19-0.613.715.06
   Asset Turnover(x)0.670.600.460.590.50
   Sales/Fixed Asset(x)1.501.601.511.931.72
   Working Capital/Sales(x)-4.82-2.35-21.7210.546.05
Efficiency Ratios
   Fixed Capital/Sales(x)0.670.630.660.520.58
   Receivable days64.6865.8579.6060.8162.76
   Inventory Days54.9461.7588.5575.5181.31
   Payable days145.49147.14160.33157.27133.22
Valuation Parameters
   PER(x)30.4592.740.0044.0658.82
   PCE(x)24.9449.82-13.1124.8340.06
   Price/Book(x)7.549.997.723.325.23
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.372.582.761.762.71
   EV/Core EBITDA(x)30.0417.89315.5528.9638.65
   EV/EBIT(x)20.8619.78-272.3536.5631.67
   EV/CE(x)1.551.571.251.011.45
   M Cap / Sales1.391.481.250.721.52
Growth Ratio
   Net Sales Growth(%)13.4429.16-19.5315.486.22
   Core EBITDA Growth(%)-37.892027.86-88.430.14-45.02
   EBIT Growth(%)-1.131761.37-116.92-35.00-26.66
   PAT Growth(%)224.98117.97-664.56-26.85-47.90
   EPS Growth(%)224.97117.97-664.56-26.85-47.89
Financial Stability Ratios
   Total Debt/Equity(x)5.357.439.404.964.17
   Current Ratio(x)0.650.500.931.231.39
   Quick Ratio(x)0.400.300.610.710.84
   Interest Cover(x)1.491.20-0.071.891.79
   Total Debt/Mcap(x)0.710.741.221.500.80

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.